[Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia]. 2011

Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
Department of Hematology, General Hospital, Tianjin Medical University, Tianjin 300052, China.

OBJECTIVE To analyze the percentage and functional changes of natural killer (NK) cell subsets in peripheral blood of severe aplastic anemia (SAA) patients before and after immunosuppressive therapy (IST) so as to evaluate the relationships between these changes and hematopoietic functions and explore the role of NK cells in the pathogenesis of SAA. METHODS By flow cytometry, the percentages of NK cells (CD3(-)CD56(+)CD16(+)) and its subsets [CD3(-)CD56(bright)CD16(-)(CD56(bright)), CD3(-)CD56(dim) CD16(+)(CD56(dim)), CD3(-)CD56(-)CD16(+)] in peripheral blood lymphocytes were detected in 12 untreated patients, 30 recovered patients and 13 normal controls respectively from April 2010 to December 2010 in our hospital. NK cells activating receptors (NKG2D and NKp46), perforin and granzyme-β of patients and normal controls were also detected. The correlation between these changes and hematopoietic functions, including the percentages of neutrophil granulocyte (ANC%), lymphocyte and reticulocyte absolute value in peripheral blood, and hyperplasia degree, percentage of granulocytes, erythrocytes, lymphocytes and megakaryocytes absolute value in bone marrow were evaluated. RESULTS (1) The percentages of NK cells (10.30% ± 6.08%) and CD56 bright cells (0.11%) in untreated patients were significantly lower than those of recovered patients (16.47% ± 8.29%, 0.68%, both P < 0.05) or normal controls (19.45% ± 6.88%, 0.53%, both P < 0.05). The percentage of CD56(dim) cells in untreated patients was significantly lower than that of normal controls (9.62% ± 6.04% vs 18.21% ± 7.16%, P < 0.05). The percentage of CD3(-)CD56(-)CD16(+) cells was significantly higher in recovered patients than that of untreated patients or normal controls (0.79% vs 0.37%, 0.41%, both P < 0.05). (2) The expression of NKp46 and perforin of NK cells in untreated (88.23%, 64.97% ± 21.61%) and recovered patients (82.97%, 66.14% ± 20.73%) were significantly higher than those of healthy controls (40.99%, 42.11% ± 27.25%, all P < 0.05). (3) The percentage of NK CD56(bright) and CD3(-)CD56(-)CD16(+) cells of patients was positively correlated with ANC% (r = 0.423, 0.609, 0.468 respectively, all P < 0.05) and the percentage of granulocytes in bone marrow (r = 0.357, 0.517, 0.434 respectively, all P < 0.05). The percentages of NK, CD56(bright), CD56(dim) and CD3(-)CD56(-)CD16(+) cells were positively correlated with the hyperplasic degree of bone marrow (r = 0.455, 0.412, 0.404, 0.451 respectively, all P < 0.05), but they were negatively correlated with the percentage of lymphocytes in bone marrow (r = -0.522, -0.435, -0.411, -0.547 respectively, all P < 0.05). The expression of NKG2D, NKp46, perforin and granzyme-β of NK cells had no correlation with hematopoiesis (all P > 0.05). CONCLUSIONS The lowered percentage of NK CD56(bright), CD56(dim) cells and a higher expression of perforin may cause the over-function of T lymphocytes and thus lead to hematopoietic failure in SAA.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
June 1986, Zhonghua nei ke za zhi,
Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
December 2000, International journal of hematology,
Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
July 1985, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
September 2023, Clinical and experimental medicine,
Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
May 1987, Journal of clinical immunology,
Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
January 1984, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
November 2015, Arthritis research & therapy,
Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
May 1986, Blood,
Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
February 2001, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis,
Zhi-shang Li, and Zong-hong Shao, and Rong Fu, and Jun Wang, and Li-juan Li, and Tian Zhang, and Hua-quan Wang, and Yu-hong Wu, and Er-bao Ruan, and Jia Song, and Wen Qu, and Hong Liu, and Li-min Xing, and Xiao-ming Wang, and Yong Liang, and Jing Guan, and Guo-jin Wang
April 2024, Immunity, inflammation and disease,
Copied contents to your clipboard!